Exploring Australian pharmacists’ perceptions and attitudes toward codeine up-scheduling from over-the-counter to prescription only
Main Article Content
Keywords
Analgesics, Codeine, Nonprescription Drugs, Pharmacies, Pharmacists, Professional Role, Attitude of Health Personnel, Health Knowledge, Attitudes, Practice, Surveys and Questionnaires, Qualitative Research, Australia
Abstract
Objective: Explore the perceptions, attitudes and experiences of pharmacists relating to the up-scheduling of low dose codeine containing analgesics and the impact on pharmacy practice.
Methods: A mixed design method was used consisting of an anonymous online questionnaire survey to quantitatively capture broad pre-scheduling change perceptions paired with a series of in-depth post-scheduling semi-structured interviews to provide a qualitative picture of the impact of codeine up-scheduling on pharmacy practice in Australia.
Results: A total of 191 pharmacists completed the quantitative survey and 10 participated in the in-depth interview. The majority of respondents supported the decision to up-schedule over-the-counter combination products containing codeine to some degree. Three main themes emerged from the data: pharmacists’ perceptions of the codeine up-scheduling decision, preparing for the up-schedule and impact of the up-schedule on pharmacy practice. Pharmacists were concerned about the impact of up-scheduling on the pharmacy business, patient access to pain relief and the diminishment of their professional role.
Conclusions: There were diverse perceptions, preparedness and impact on practice regarding the up-scheduling of low dose codeine products. Further research should be conducted to gauge if and how these perceptions have changed over time and to identify whether pain is being managed more effectively post codeine up-scheduling.
References
2. Frei MY, Nielsen S, Dobbin MD, Tobin CL. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. Med J Aust. 2010;193(5):294‐296. https://doi.org/10.5694/j.1326-5377.2010.tb03911.x
3. Nielsen S, Van Hout MC. Over-the-Counter Codeine-from Therapeutic Use to Dependence, and the Grey Areas in Between. Curr Top Behav Neurosci. 2017;34:59‐75. https://doi.org/10.1007/7854_2015_422
4. Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM; U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947‐954. https://doi.org/10.7326/0003-4819-137-12-200212170-00007
5. Mill D, Johnson JL, Cock V, Monaghan E, Hotham ED. Counting the cost of over-the-counter codeine containing analgesic misuse: A retrospective review of hospital admissions over a 5 year period. Drug Alcohol Rev. 2018;37(2):247‐256. https://doi.org/10.1111/dar.12595
6. Nielsen S, MacDonald T, Johnson JL. Identifying and treating codeine dependence: a systematic review. Med J Aust. 2018;208(10):451‐461. https://doi.org/10.5694/mja17.00749
7. Carney T, Wells J, Bergin M, Dada S, Foley M, McGuiness P, Rapca A, Rich E, Van Hout MC. A Comparative exploration of community pharmacists’ views on the nature and management of over-the-counter (OTC) and prescription codeine misuse in three regulatory regimes: Ireland, South Africa and the United Kingdom. Int J Ment Health Addict. 2016;14(4):351-369. https://doi.org/10.1007/s11469-016-9640-z
8. Therapeutic Goods Administration. Codeine information hub: Codeine use can be harmful. Therapeutic Goods Administration; 2018; Available at: https://www.tga.gov.au/codeine-information-hub-codeine-use-can-be-harmful (accessed May 2, 2020).
9. Hamer AM, Spark MJ, Wood PJ, Roberts E. The upscheduling of combination analgesics containing codeine: the impact on the practice of pharmacists. Res Social Adm Pharm. 2014;10(4):669‐678. https://doi.org/10.1016/j.sapharm.2013.08.004
10. Australian Institute of Health and Welfare. National Drug Strategy Household Survey detailed report 2016. Drug statistics series no. 31. Cat. no. PHE 214 Canberra: AIHW; 2017; Available at: https://www.aihw.gov.au/reports/illicit-use-of-drugs/ndshs-2016-detailed/contents/table-of-contents (accessed May 2, 2020).
11. Australian Institute of Health and Welfare. National Drug Strategy Household Survey detailed report 2013. Drug statistics series no. 28. Cat. no. PHE 183. Canberra: AIHW; 2014; Available at: https://www.aihw.gov.au/reports/illicit-use-of-drugs/ndshs-2016-detailed/contents/table-of-contents (accessed May 2, 2020).
12. Cairns R, Brown JA, Buckley NA. The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia's largest poisons centre. Addiction. 2016;111(10):1848‐1853. https://doi.org/10.1111/add.13450
13. Roberts DM, Nielsen S. Changes for codeine. Aust Prescr. 2018;41(1):2‐3. https://doi.org/10.18773/austprescr.2018.006
14. Therapeutic Goods Administration. Final decision on re-scheduling of codeine: frequently asked questions. Therapeutic Goods Administration; 2016; Available at: https://www.tga.gov.au/final-decision-re-scheduling-codeine-frequently-asked-questions (accessed May 4, 2020).
15. Chan V, Tran H. Purchasing Over-the-counter medicines from Australian pharmacy: What do the pharmacy customers value and expect?. Pharm Pract (Granada). 2016;14(3):782. https://doi.org/10.18549/pharmpract.2016.03.782
16. QSR. NVivo qualitative data analysis software. 12 ed. Melbourne: QSR International Pty Ltd.; 2018.
17. Mishriky J, Stupans I, Chan V. Pharmacists' views on the upscheduling of codeine-containing analgesics to 'prescription only' medicines in Australia. Int J Clin Pharm. 2019;41(2):538‐545. https://doi.org/10.1007/s11096-019-00804-8
18. McCoy J, Bruno R, Nielsen S. Attitudes in Australia on the upscheduling of over-the-counter codeine to a prescription-only medication. Drug Alcohol Rev. 2018;37(2):257‐261. https://doi.org/10.1111/dar.12568
19. Moore RA, Wiffen PJ, Derry S, Maguire T, Roy YM, Tyrrell L. Non-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;2015(11):CD010794. https://doi.org/10.1002/14651858.cd010794.pub2
20. Middleton M, Nielsen S. Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data. Int J Drug Policy. 2019;74:170‐173. https://doi.org/10.1016/j.drugpo.2019.08.008
21. Cairns R, Schaffer AL, Brown JA, Pearson SA, Buckley NA. Codeine use and harms in Australia: evaluating the effects of re-scheduling. Addiction. 2020;115(3):451‐459. https://doi.org/10.1111/add.14798
22. Haggan M. Review codeine: Patients taken by surprise. Austral J Pharm. 2018;99:26.
23. Mishriky J, Stupans I, Chan V. Expanding the role of Australian pharmacists in community pharmacies in chronic pain management - a narrative review. Pharm Pract (Granada). 2019;17(1):1410. https://doi.org/10.18549/pharmpract.2019.1.1410
24. Australian Government Department of Health. Chronic Pain Medscheck Trial . Available at: http://6cpa.com.au/chronic-pain-medscheck-trial/chronic-pain-medscheck-trial/ (accessed May 4, 2020).
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.